comparemela.com

Page 35 - Tdoc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Q1 2022 Earnings Estimate for Teladoc Health, Inc Issued By Piper Sandler (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC – Get Rating) – Equities researchers at Piper Sandler dropped their Q1 2022 EPS estimates for Teladoc Health in a note issued to investors on Tuesday, March 8th. Piper Sandler analyst S. Wieland now expects that the health services provider will post earnings of ($0.60) per share for the quarter, down […]

$571 45 Million in Sales Expected for Teladoc Health, Inc (NYSE:TDOC) This Quarter

Wall Street brokerages predict that Teladoc Health, Inc. (NYSE:TDOC – Get Rating) will announce $571.45 million in sales for the current quarter, Zacks reports. Seven analysts have made estimates for Teladoc Health’s earnings, with the lowest sales estimate coming in at $568.02 million and the highest estimate coming in at $583.83 million. Teladoc Health posted […]

Teladoc Health, Inc (NYSE:TDOC) Insider Adam C Vandervoort Sells 3,513 Shares of Stock

Teladoc Health, Inc. (NYSE:TDOC – Get Rating) insider Adam C. Vandervoort sold 3,513 shares of Teladoc Health stock in a transaction that occurred on Thursday, March 3rd. The shares were sold at an average price of $70.24, for a total transaction of $246,753.12. The transaction was disclosed in a document filed with the SEC, which […]

Future Financial Wealth Managment LLC Acquires Shares of 300 Teladoc Health, Inc (NYSE:TDOC)

Future Financial Wealth Managment LLC acquired a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 300 shares of the health services provider’s stock, valued at approximately $29,000. A number […]

Teladoc Health (NYSE:TDOC) Releases FY 2022 Earnings Guidance

Teladoc Health (NYSE:TDOC – Get Rating) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $-1.600-$-1.400 for the period, compared to the Thomson Reuters consensus estimate of $-1.780. The company issued revenue guidance of $2.55 billion-$2.65 billion, compared to the consensus revenue estimate […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.